TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31136656

Group type: EXPERIMENTAL
Intervention: High-fat load (150 g of fat)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fat load with fructose (3 doses of 50 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-fat load with glucose (3 doses of 50 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Repeated doses of fructose (3 doses of 50 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glucose (3 doses of 50 g)
Number of subjects: 10
Study: 28412240

Group type: EXPERIMENTAL
Intervention: High mental effort (HME)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low mental effort (LME)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-training control (CTRL)
Number of subjects: 18
Study: 25976238

Group type: EXPERIMENTAL
Intervention: Oral Morphine Sulfate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Loading dose of Phenobarbital followed by tapering dose
Number of subjects: 60
Study: 23043876

Group type: EXPERIMENTAL
Intervention: Low intensity two-legged exercise
Number of subjects: 8
Study: 22103649

Group type: EXPERIMENTAL
Intervention: Tooth-implant-supported fixed prostheses (TISPs)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Implant-supported prostheses (ISPs)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both TISPs and ISPs
Number of subjects: 13
Study: 19563522

Group type: EXPERIMENTAL
Intervention: Disease-specific nutrition treatment (standard diet plus a 400-mL oral supplement or specific enteral formula enriched with protein, 20% of total calories, arginine, zinc, and vitamin C)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard nutrition (hospital diet or standard enteral formula; 16% calories from protein)
Number of subjects: 28
Study: 16389668

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg (HYD) with alcohol (ALC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg (CET) with alcohol (ALC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg (RUP) with alcohol (ALC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg (RUP) with alcohol (ALC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Alcohol alone (ALC)
Number of subjects: 18
Study: 16296259

Group type: EXPERIMENTAL
Intervention: Professional toothcleaning (PTC), oral hygiene instruction, and motivation (test group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study: 10989320

Group type: EXPERIMENTAL
Intervention: Muscarinic receptor stimulation by metacholine (Mch)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nitroprusside (SNP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 17-beta estradiol (E) infusion (20 ng/min)
Number of subjects: 6
Study: 1889973

Group type: EXPERIMENTAL
Intervention: PMMA membrane dialyzer
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cuprophane membrane dialyzer
Number of subjects: 200
Study: 6361737

Group type: EXPERIMENTAL
Intervention: Y connector system filled with sodium hypochlorite
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard Oreopoulos CAPD system
Number of subjects: 62
Study: 30794565

Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stride length
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trailing limb angle
Number of subjects: 20
Study: 29803427

Group type: EXPERIMENTAL
Intervention: Vertical extraction system
Number of subjects: 240

Group type: COMPARATOR
Intervention: Conventional tooth extraction techniques
Number of subjects: 240
Study: 27372219

Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment (21mg) with counseling for 8 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Increase in craving
Number of subjects: 180
Study: 24343281

Group type: EXPERIMENTAL
Intervention: Infliximab use
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: PCDAI and SES
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: PCDAI
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: SES
Number of subjects: 499
Study: 22489806

Group type: EXPERIMENTAL
Intervention: Real plants
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Posters of plants
Number of subjects: 457

Group type: COMPARATOR
Intervention: No nature (control)
Number of subjects: 457
Study: 19819203

Group type: EXPERIMENTAL
Intervention: Cola-flavoured ORS
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Strawberry-flavoured ORS
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Neutral solution
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Fruit-flavoured ORS
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Overall preference
Number of subjects: 116
Study: 17713794

Group type: EXPERIMENTAL
Intervention: Low-cost rehabilitation program with a behavioural element
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individual exercise therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 90
Study: 16018337

Group type: EXPERIMENTAL
Intervention: High-frequency EEG (HFE)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low-frequency band (LFB)
Number of subjects: 13
Study: 12757116

Group type: EXPERIMENTAL
Intervention: Pump-assisted nutrition (G1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gravity-controlled nutrition (G2)
Number of subjects: 50
Study: 10692926

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous infusion of midazolam (0.2 mg/ml of normal saline at a rate of 1 mg/h)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 48
Study: 9115974

Group type: EXPERIMENTAL
Intervention: Soya infant formula
Number of subjects: 19

Group type: COMPARATOR
Intervention: Infant milk
Number of subjects: 19
Study: 1787974

Group type: EXPERIMENTAL
Intervention: Clindamycin oral rinse
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo rinse (normal saline)
Number of subjects: 20
Study: 6382127

Group type: EXPERIMENTAL
Intervention: Flubendazole (FZ) treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study: 29550314

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin I (hsTnI) concentrations
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 1844
Study: 28557049

Group type: EXPERIMENTAL
Intervention: REAL group (rTMS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: SHAM group (control)
Number of subjects: 44
Study: 26460634

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Concentric training
Number of subjects: 28
Study: 25454175

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT) with 5 fluorouracil (5FU) and Folinic Acid (6 cycles) in Arm B.
Number of subjects: 655

Group type: COMPARATOR
Intervention: Follow-up (no adjuvant chemotherapy) in Arm A.
Number of subjects: 655
Study: 22198972

Group type: EXPERIMENTAL
Intervention: Reward prediction error (RPE) induced by discarding chosen outcomes for personal payoffs.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Reward prediction error (RPE) induced by discarding chosen outcomes for charity payoffs.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Outcome orientation in charitable giving.
Number of subjects: 33
Study: 21440831

Group type: EXPERIMENTAL
Intervention: Topical phenylephrine (0.1 ml, 10%) administered twice in 5 minutes before surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: No topical phenylephrine (control group)
Number of subjects: 57
Study: 17553743

Group type: EXPERIMENTAL
Intervention: 0.5mg/24h rotigotine
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: 1mg/24h rotigotine
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: 2mg/24h rotigotine
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: 3mg/24h rotigotine
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: 4mg/24h rotigotine
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 16611722

Group type: EXPERIMENTAL
Intervention: Intermittent ice application (n = 43)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard ice application (n = 46)
Number of subjects: 89
Study: 14662576

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride for smoking cessation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Nonsmoking adult or children in the home
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Progress in stage of change
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Baseline preparatory stage of change
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Having a nonsmoking partner
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Having children in the home
Number of subjects: 600
Study: 11122830

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m(2) every 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m(2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vinorelbine or ifosfamide (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care (control)
Number of subjects: 0
Study: 8707476

Group type: EXPERIMENTAL
Intervention: Tacrine treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-responders (Tacrine treatment)
Number of subjects: 12
Study: 2000843

Group type: EXPERIMENTAL
Intervention: Higher educational level
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Sports activity score
Number of subjects: 512

Group type: COMPARATOR
Intervention: Heavy smoking
Number of subjects: 512
Study: 6873418

Group type: EXPERIMENTAL
Intervention: Zinc sulfate per os for 8 weeks (Ps group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc sulfate per os for 8 weeks (PA group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment (Ps and PA groups)
Number of subjects: 0
Study: 30719553

Group type: EXPERIMENTAL
Intervention: Clinical examination including transvaginal ultrasound (CE/US)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 3 Tesla magnetic resonance imaging (MRI)
Number of subjects: 26
Study: 28635018

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg
Number of subjects: 268

Group type: COMPARATOR
Intervention: ustekinumab
Number of subjects: 268
Study: 27004293

Group type: EXPERIMENTAL
Intervention: Bicortical fixation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Unicortical fixation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Indirect sinus elevation
Number of subjects: 38
Study: 24642082

Group type: EXPERIMENTAL
Intervention: Email and SMS prompts to revisit the intervention website
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Prompts announcing new animated videos
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Prompts about games related to (non-)smoking
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Low socioeconomic status (SES) children in the prompt group
Number of subjects: 1124
Study: 22356584

Group type: EXPERIMENTAL
Intervention: Sertindole (16 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20307393

Group type: EXPERIMENTAL
Intervention: Few Touch application (mobile phone-based self-management tool)
Number of subjects: 12
Study: 17685733

Group type: EXPERIMENTAL
Intervention: Shared decision making (SDM) program on antipsychotic drug choice
Number of subjects: 107

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 107
Study: 15849749

Group type: EXPERIMENTAL
Intervention: Educational material provided 3 times yearly
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Education and 800 ml free broad spectrum sunscreens with SPF 25 provided yearly
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Parents informed on study purpose and sun protection measures only at an initial educational meeting
Number of subjects: 1232
Study: 12109619

Group type: EXPERIMENTAL
Intervention: OGTT (Oral Glucose Tolerance Test) at baseline and 3-year follow-up
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Assessment of peripheral insulin sensitivity using HOMA index and a novel index from OGTT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Follow-up measurements of fasting glycemia
Number of subjects: 14
Study: 9788383

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol gut lavage taken the same morning as colonoscopy (Group 1)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Polyethylene glycol gut lavage taken the afternoon before colonoscopy (Group 2)
Number of subjects: 317
Study: 7624100

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Other antibiotics or non-treated controls
Number of subjects: 1173
Study: 2794250

Group type: EXPERIMENTAL
Intervention: Bipolar electrode pair at different stimulus currents
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Single bipolar electrode pairs with different spatial extents (1.5 mm and 4.5 mm)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Two loudness balanced bipolar masker electrode pairs activated within a stimulus period
Number of subjects: 1
Study: 208462

Group type: EXPERIMENTAL
Intervention: Levamisole, 50 mg three times daily for 3 days
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 31494945

Group type: EXPERIMENTAL
Intervention: Artificial colloid priming group (AC group, n = 33)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Artificial colloid combined with human serum albumin priming group (ACA group, n = 32)
Number of subjects: 65
Study: 30877051

Group type: EXPERIMENTAL
Intervention: Attachment‐Based Family Therapy (ABFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Family‐Enhanced NonDirective Supportive Therapy (FE‐NST)
Number of subjects: 0
Study: 29147888

Group type: EXPERIMENTAL
Intervention: Parental presence/absence (PPA) technique
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (non-pharmacological techniques)
Number of subjects: 61
Study: 24480912

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 23548250

Group type: EXPERIMENTAL
Intervention: Guided internet-delivered acceptance and commitment therapy (ACT) for 7 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Moderated online discussion forum (Control)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Guided internet-delivered acceptance and commitment therapy (ACT)
Number of subjects: 76
Study: 21878168

Group type: EXPERIMENTAL
Intervention: ITBVI group (17 patients)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (16 patients)
Number of subjects: 33
Study: 18952810

Group type: EXPERIMENTAL
Intervention: Integrated morphological awareness intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 16775680

Group type: EXPERIMENTAL
Intervention: NSAIDs (paracetamol or parecoxib/valdecoxib) with piritramid
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (piritramid only)
Number of subjects: 180
Study: 12841663

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation with 5-fluorouracil (350 mg/m2/day) and folinic acid (10 mg/m2) administered as intravenous bolus on days 1-5 and 29-33 of radiotherapy, followed by surgery after 4-6 weeks.
Number of subjects: 27
Study: 11036135

Group type: EXPERIMENTAL
Intervention: Preincisional bupivacaine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Postincisional bupivacaine
Number of subjects: 74
Study: 10369641

Group type: EXPERIMENTAL
Intervention: Skeletonizing technique (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Classical pedicle preparation technique (Group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Papaverine soaking
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass flow
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transit-time flow measurement
Number of subjects: 20
Study: 1313116

Group type: EXPERIMENTAL
Intervention: Lomefloxacin
Number of subjects: 182

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 182
Study: 2939794

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 100 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 150 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 200 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 9
Study: 29599611

Group type: EXPERIMENTAL
Intervention: Daclatasvir plus asunaprevir (DUAL) - daclatasvir 60 mg once daily and asunaprevir 100 mg twice daily for 24 weeks
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo (12 weeks) followed by DUAL treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: DUAL treatment during double-blind phase
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: DUAL treatment during 24 weeks (combined arms)
Number of subjects: 207
Study: 26913649

Group type: EXPERIMENTAL
Intervention: Vitamin K deficiency (PIVKA-II > 2 μg/L)
Number of subjects: 500
Study: 25047001

Group type: EXPERIMENTAL
Intervention: Primary delivery of the anterior shoulder
Number of subjects: 650

Group type: COMPARATOR
Intervention: Primary delivery of the posterior shoulder
Number of subjects: 650
Study: 22230058

Group type: EXPERIMENTAL
Intervention: bFGF eye drops
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (saline drops)
Number of subjects: 100
Study: 20427682

Group type: EXPERIMENTAL
Intervention: Intensive glycemic treatment strategy targeting A1C <6.0%
Number of subjects: 10251

Group type: COMPARATOR
Intervention: Standard glycemic treatment strategy targeting A1C 7.0‐7.9%
Number of subjects: 10251
Study: 18771374

Group type: EXPERIMENTAL
Intervention: Etoricoxib, 120 mg/day for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 20
Study: 15559483

Group type: EXPERIMENTAL
Intervention: 7.5% icodextrin/1.36% glucose combination dialysate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control: 7.5% icodextrin alone
Number of subjects: 8
Study: 11516109

Group type: EXPERIMENTAL
Intervention: Fludarabine (FAMP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin and prednisone (CAP)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Quality-adjusted survival analysis (Q-TWiST)
Number of subjects: 92
Study: 9257067

Group type: EXPERIMENTAL
Intervention: cisplatin/vinblastine with hydrazine sulfate (HS)
Number of subjects: 291

Group type: COMPARATOR
Intervention: cisplatin/vinblastine with placebo
Number of subjects: 291
Study: 8388949

Group type: EXPERIMENTAL
Intervention: Dexamethasone (early treatment group, n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dexamethasone (late treatment group, n = 11)
Number of subjects: 21
Study: 3481361

Group type: EXPERIMENTAL
Intervention: Incision and drainage with subsequent oral antibiotics and oral hydration
Number of subjects: 27

Group type: COMPARATOR
Intervention: Incision and drainage with subsequent hospitalization for intravenous antibiotics and hydration
Number of subjects: 27
Study: 29782187

Group type: EXPERIMENTAL
Intervention: Vitamin D3 3,800 IU daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Vitamin D3 400 IU daily
Number of subjects: 13
Study: 27836017

Group type: EXPERIMENTAL
Intervention: Intervention group (watched a video, received online information, tracked intake using a mobile application for 12 weeks)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 23945164

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual needle placement
Number of subjects: 60
Study: 22929243

Group type: EXPERIMENTAL
Intervention: Isolation plus de‐epithelialization group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isolation group
Number of subjects: 60
Study: 20688403

Group type: EXPERIMENTAL
Intervention: Cochlear implants (CIs)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Normal hearing (NH)
Number of subjects: 63
Study: 18782876

Group type: EXPERIMENTAL
Intervention: High-morning hydrocortisone (HC) dose (50% of daily dose in the morning)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-evening hydrocortisone (HC) dose (50% of daily dose in the evening)
Number of subjects: 15
Study: 16884553

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil-based anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane-fentanyl-based anaesthesia
Number of subjects: 50
Study: 14654485

Group type: EXPERIMENTAL
Intervention: QuickSeal system (gelatin sponge closure device)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Manual compression (control)
Number of subjects: 141
Study: 11107790

Group type: EXPERIMENTAL
Intervention: Phagocytic activity of PMN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phagocytic activity connected with intracellular oxygen metabolism
Number of subjects: 0

Group type: COMPARATOR
Intervention: PMN activity tests (phagocytosis, NBT test)
Number of subjects: 0
Study: 8800215

Group type: EXPERIMENTAL
Intervention: Handrim with an oval 25 by 30 mm diameter (LR)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Handrim with an 18 mm diameter (SR)
Number of subjects: 6
Study: 1622907

Group type: EXPERIMENTAL
Intervention: 60 mg aspirin daily
Number of subjects: 46

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 46
Study: 6370703

Group type: EXPERIMENTAL
Intervention: Theophylline (T) 5.0 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enprofylline (E) 1.5 mg/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (P) 0.9% saline
Number of subjects: 8
Study: 30783648

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the left posterior parietal cortex, applied in either eight or 16 trains.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the left posterior parietal cortex.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (patients without neglect).
Number of subjects: 60